TK Rao, Ph.D.
Founder and Chairman of the Board
Dr. Rao, founder and Chairman of the Board of the Directors at Integrated Laboratory Systems, Inc. (ILS). He graduated with a Ph.D. from Florida State University. Before founding ILS, he worked as a Staff Biologist at Oak Ridge National Laboratory in Tennessee and Senior Research Scientist at Northrop Services, Inc. in North Carolina. Dr. Rao served on various professional organizations such as The Environmental Mutagen Society, Genetic Toxicology and Environmental Mutagen Society, Southeastern Cancer Research Association and The National Contract Management Association. He has edited one reference book and has published over 150 technical publications and presentations.
Tom Goldsworthy, Ph.D.
President and Chief Executive Officer
Dr. Goldsworthy is not only the President and CEO for Integrated Laboratory Systems, Inc. (ILS) he is also a member of the Board of Trustees. Prior to his current position, he served as the Chief Operating Officer, Senior Vice President, and the Director of the Health Sciences Division at ILS. As President and CEO, Dr. Goldsworthy works closely with the Chairman of the Board to provide the executive leadership for making ILS a successful company and a cherished place to work by all employees. Dr. Goldsworthy has over 25 years of experience as an experimental pathologist and toxicologist, specializing in cancer research, mechanisms of disease, and human risk assessment. Before joining ILS, Dr. Goldsworthy served as a Staff Scientist at the Chemical Industry Institute of Toxicology (Research Triangle Park, NC), where he directed the carcinogenesis research program investigating the role of growth alterations, cell cycle regulation, gene expression, and gene mutation in the induction of cancer. He is widely recognized by his peers for his scientific vision and integrity, management experience, and motivational skills. Dr. Goldsworthy received his Ph.D. in Pathology and Oncology from the McArdle Laboratory for Cancer Research, University of Wisconsin-Madison.
Les Recio, Ph.D. DABT
VP, Research and Development
Dr. Recio is the Chief Scientist at ILS. Dr. Recio’s responsibilities include defining the scope of work, providing oversight and organization for all studies, and training of staff in genetic and molecular toxicology methods. He provides supervision of all genetic toxicology and genomic based projects through prioritization, coordination, and scheduling of all activities. Dr. Recio guides the development of new capabilities for novel approaches for use in the assessment of genotoxicity. He interacts with ILS staff to develop new programs and provide new avenues for research projects. Dr. Recio was appointed to the Editorial Board of Toxicological Sciences and was elected to the North Carolina Society of Toxicology Board of Councilors in 2006. Dr. Recio received both his M.S. and Ph.D. in Toxicology from the University of Kentucky. After completion of a postdoctoral fellowship in 1989, Dr. Recio became a Senior Research Fellow in the Cellular and Molecular Toxicology Department of the Chemical Industry Institute of Toxicology (CIIT). While at CIIT (1989 to 2002), Dr. Recio’s research group published more than 70 manuscripts in peer-reviewed literature in the area of molecular biology, genetic toxicology, and carcinogenesis.
David Allen, Ph.D.
VP, Science and Strategy
As the VP of Science and Strategy at ILS, Dr. Allen provides scientific leadership, management, and direction to ILS’ programs and core services. He works closely with all scientific staff to support the planning and execution of ILS growth plans, and leads staff planning and employee development. Dr. Allen has over 15 years of experience in regulatory toxicology, test method validation, and in vitro biology. At ILS, Dr. Allen has spent over 8 years providing contract support and leadership for the National Toxicology Program’s Center for the Evaluation of Alternative Toxicological Methods (NICEATM). Prior to joining ILS, he was a toxicologist for the Food and Drug Administration, Center for Drug Evaluation and Research, where he was responsible for evaluating toxicological and pharmacological data for investigational new drug applications. Dr. Allen received his B.S. in Zoology from North Carolina State University, his M.S. in Biological Sciences from the University of North Carolina at Wilmington, and his Ph.D. in Cell Biology also from North Carolina State University.
Brad Blackard, MSPH
VP, Business Management
Mr. Blackard has over 23 years of experience in the environmental health science industry and over 15 years of experience managing federal contracts. After serving as a Program Manager for six years, Director of Operations for two years, and the Chief Operating Officer for five years, he is now the Vice-President of Business Operations for ILS. His role includes managing the daily and long-term business operations of the company including Finance, Contracts, Business Development, Human Resources, Information Technology, Quality Assurance, Health and Safety, and Facility Administration. He works with the CEO to assure the aggressive and successful growth of the company. Mr. Blackard holds a B.S. in Zoology from North Carolina State University, and a MSPH in Environmental Sciences and Engineering, Environmental Management and Policy from the University of North Carolina at Chapel Hill.
Kevin Causey, MBA
VP, Commerical Business Development
Phone: 919 281-1110
Mr. Causey has 10 years of experience in the pharmaceutical, health science, and chemical industries. After several years serving in a dual role overseeing Project Management and Commercial Business his focus has shifted to direct ILS’s commercial business strategies. As Director of Commercial Development Mr. Causey’s primary responsibilities are sales, marketing, customer engagement, and partnerships. He is a member of the Senior Leadership Team with the CEO and Board of Directors to strategically position ILS for continued industry leadership in the future. Mr. Causey received a B.S. in Biological Sciences from North Carolina State University in 2001, and an MBA from Pfeiffer University in 2006.
Barbara Vinesett, CPA
Director of Finance
Ms. Vinesett has over 20 years of accounting/finance experience. She is responsible for all aspects of ILS’ financial and accounting operations, and resource allocation. Ms. Vinesett is a Certified Public Account and holds a B.S. in Accounting from Greensboro College.
Mary Mulleady, CPCM, PMP
Director of Business Management/Federal Business Development
Ms. Mulleady has over 23 years of experience in Contract Management, including oversight and administration of both Federal and Commercial contracts. She manages the Contracts, Purchasing, and Travel departments for both ILS and ILS Genomics. She also manages Federal Business Development for both companies which includes identification of opportunities, interaction with procurement officials, and preparation of both Technical and Business proposals. Ms. Mulleady holds a B.A. from Virginia Polytechnic Institute and State University. She also holds Project Management Professional (PMP) and Certified Professional Contracts Manager (CPCM) certifications.
Jason Shannon, PHR
Director of Human Resources
Mr. Shannon has over 15 years of human resources experience. He works closely with executives, directors, managers, and staff, serving as the principal contact for all human resource issues. He is responsible for developing best practice policies and procedures in the areas of compensation, benefits, recruitment, performance management, and labor relations. Mr. Shannon holds a B.S. in Human Resources Management from Barton College and is certified as a Professional in Human Resources from the Human Resources Certification Institute.